|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Enalapril#Overdosage]] |
| {{Enalapril}}
| |
| {{CMG}}; {{AE}} {{AM}}
| |
| | |
| ==OVERDOSAGE==
| |
| | |
| Limited data are available in regard to overdosage in humans.
| |
| | |
| Single oral doses of enalapril above 1,000 mg/kg and ≥1,775 mg/kg were associated with lethality in mice and rats, respectively.
| |
| | |
| The most likely manifestation of overdosage would be hypotension, for which the usual treatment would be intravenous infusion of normal saline solution.
| |
| | |
| Enalaprilat may be removed from general circulation by [[hemodialysis]] and has been removed from [[neonatal circulation]] by [[peritoneal dialysis]] (see WARNINGS, Anaphylactoid reactions during membrane exposure).<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = VASOTEC (ENALAPRIL MALEATE) TABLET VASOTEC (ENALAPRIL MALEATE) TABLET [BTA PHARMACEUTICALS INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d181743-a0fc-4d17-953d-b17a936f9ecc | publisher = | date = | accessdate = }}</ref>
| |
| | |
| ==References==
| |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |